NANOG表达对食管鳞状细胞癌进展的促进作用OA
NANOG expression promotes progression in esophageal squamous cell carcinoma
目的 探讨NANOG在食管鳞状细胞癌(esophageal squamous cell carcinoma,ESCC)组织中的表达特征及其对ESCC细胞增殖、迁移的影响.方法 采用免疫组化法检测107例ESCC及癌旁食管黏膜组织中NANOG、Survivin表达,并分析其与临床病理特征和患者预后的关系.采用慢病毒转染构建过表达NANOG的食管癌(KYSE30)细胞模型,通过CCK-8、平板克隆、划痕实验、Transwell小室实验及流式细胞术,分别评估KYSE30细胞增殖、迁移能力及细胞周期变化.应用Western blot检测过表达NANOG对E-cadherin、vimentin、Survivin、VEGF、Cyclin D1的表达影响.结果 48.6%的ESCC呈NANOG细胞质阳性,其与患者无进展生存期呈负相关(P=0.001),而与总生存期无关(P=0.077).75.7%的ESCC呈NANOG细胞核阳性,其与淋巴结分期呈正相关(P=0.003),但与患者总生存期、无进展生存期无关(P=0.961,P=0.972).功能实验结果显示,NANOG过表达可显著增强KYSE30细胞的增殖与迁移能力,提高S期细胞比例,降低细胞凋亡率;同时下调E-cadherin表达,上调vimentin、Survivin、VEGF和Cyclin D1的表达.结论 NANOG细胞质阳性可能作为ESCC肿瘤进展的标志物,未来有望成为ESCC的治疗靶点.
Objective To investigate the expression characteristics of NANOG in esophageal squamous cell car-cinoma(ESCC)tissues and its influence on the proliferation and migration of ESCC cells.Methods Immunohisto-chemistry was used to detect the expression of NANOG and Survivin in 107 cases of ESCC tissues and adjacent esopha-geal mucosal tissues and their correlations with clinicopathological features as well as patient prognosis were analyzed.A NANOG-overexpressing ESCC cell model(KYSE30)was constructed using lentiviral transfection.Cell prolifera-tion,migration,cell cycle distribution and apoptosis in KYSE30 cells were assessed using CCK-8,colony formation,scratch assay,Transwell chamber assay and flow cytometry.Western blot was performed to detect the effects of NANOG overexpression on the expression of E-cadherin,vimentin,Survivin,VEGF and Cyclin D1.Results NANOG cytoplasmic positivity was observed in 48.6%of ESCC cases,which was significantly negatively correlated with progression-free survival(P=0.001),but showed no significant association with overall survival(P=0.077).NANOG nuclear positivity was detected in 75.7%of ESCC cases,which was positively correlated with lymph node staging(P=0.003),but was not associated with overall survival or progression-free survival(P=0.961,P=0.972).Functional assays demonstrated that NANOG overexpression significantly promoted KYSE30 cell prolifera-tion and migration,increased the S-phase cell population,and suppressed apoptosis.Concurrently,it downregulated E-cadherin while upregulating the expression of vimentin,Survivin,VEGF,and Cyclin D1.Conclusion The cyto-plasmic positive expression of NANOG may serve as a biomarker for tumor progression in ESCC and is expected to be-come a potential therapeutic target for ESCC in the future.
王慧;苏丽萍;李梦研;滕晓东
省部共建中亚高发病成因与防治国家重点实验室/浙江大学医学院附属第一医院病理科,杭州 310003省部共建中亚高发病成因与防治国家重点实验室/新疆医科大学第一附属医院病理科,乌鲁木齐 830054省部共建中亚高发病成因与防治国家重点实验室/新疆医科大学第一附属医院病理科,乌鲁木齐 830054省部共建中亚高发病成因与防治国家重点实验室/浙江大学医学院附属第一医院病理科,杭州 310003
医药卫生
食管鳞状细胞癌NANOGSurvivin预后增殖迁移
esophageal squamous cell carcinomaNANOGSurvivinprognosisproliferationmigration
《临床与实验病理学杂志》 2026 (1)
38-45,55,9
省部共建中亚高发病成因与防治国家重点实验室开发课题基金(SKL-HIDCA-2019-36)、省部共建中亚高发病成因与防治国家重点实验室开发课题基金(SKL-HIDCA-2021-27) State Key Laboratory of Pathogenesis,Prevention and Treatment of High Incidence Diseases in Cen-tral Asia Fund(SKL-HIDCA-2019-36)State Key Laboratory of Pathogenesis,Prevention and Treatment of High Inci-dence Diseases in Central Asia Fund(SKL-HIDCA-2021-27)
评论